Literature DB >> 16172611

Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder.

T Roman, G V Polanczyk, C Zeni, J P Genro, L A Rohde, M H Hutz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16172611     DOI： 10.1038/sj.mp.4001743

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  16 in total

1.  Sequence analysis of the ADRA2A coding region in children affected by attention deficit hyperactivity disorder.

Authors:  Taryn Castro; Heidi Eliana Mateus; Dora Janeth Fonseca; Diego Forero; Carlos Martín Restrepo; Claudia Talero; Alberto Vélez; Paul Laissue
Journal:  Neurol Sci       Date:  2013-11-01       Impact factor: 3.307

2.  Effects of the serotonin transporter (5-HTTLPR) and α2A-adrenoceptor (C-1291G) genotypes on substance use in children and adolescents: a longitudinal study.

Authors:  Liis Merenäkk; Jarek Mäestu; Niklas Nordquist; Jüri Parik; Lars Oreland; Helle-Mai Loit; Jaanus Harro
Journal:  Psychopharmacology (Berl)       Date:  2010-12-08       Impact factor: 4.530

3.  A preliminary analysis of the phenomenology of skin-picking in Prader-Willi syndrome.

Authors:  Jessica R Morgan; Eric A Storch; Douglas W Woods; Danielle Bodzin; Adam B Lewin; Tanya K Murphy
Journal:  Child Psychiatry Hum Dev       Date:  2010-08

Review 4.  Molecular genetics of attention deficit hyperactivity disorder.

Authors:  Stephen V Faraone; Eric Mick
Journal:  Psychiatr Clin North Am       Date:  2010-03

5.  Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD.

Authors:  Verônica Contini; Marcelo M Victor; Caio C S Cerqueira; Evelise R Polina; Eugênio H Grevet; Carlos A I Salgado; Rafael G Karam; Eduardo S Vitola; Paulo Belmonte-de-Abreu; Claiton H D Bau
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-11-20       Impact factor: 5.270

6.  Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.

Authors:  Tanya E Froehlich; Jeffery N Epstein; Todd G Nick; Maria S Melguizo Castro; Mark A Stein; William B Brinkman; Amanda J Graham; Joshua M Langberg; Robert S Kahn
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-09-15       Impact factor: 8.829

Review 7.  Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.

Authors:  Tanya E Froehlich; James J McGough; Mark A Stein
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

8.  Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type.

Authors:  T L da Silva; T G Pianca; T Roman; M H Hutz; S V Faraone; M Schmitz; L A Rohde
Journal:  J Neural Transm (Vienna)       Date:  2008-01-16       Impact factor: 3.575

9.  Tobacco smoking and the ADRA2A C-1291G polymorphism.

Authors:  A P Prestes; F Z C Marques; M H Hutz; T Roman; C H D Bau
Journal:  J Neural Transm (Vienna)       Date:  2007-07-06       Impact factor: 3.575

10.  Adrenergic neurotransmitter system transporter and receptor genes associated with atomoxetine response in attention-deficit hyperactivity disorder children.

Authors:  Li Yang; Qiujin Qian; Lu Liu; Haimei Li; Stephen V Faraone; Yufeng Wang
Journal:  J Neural Transm (Vienna)       Date:  2012-12-25       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.